Experimental treatment for pancreatic cancer could be breakthrough for patients

New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a personalized mRNA vaccine for pancreatic cancer at Memorial Sloan Kettering, who has now been cancer-free for six years. NBC News’ Anne Thompson has a closer look at how it works.

Go to News Site